XML 101 R29.htm IDEA: XBRL DOCUMENT v3.20.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Assets Measured On Recurring Basis
The following table presents the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2019:
 
 
 
 
Fair Value Measurements at Reporting Date Using
 
 
Total
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant other
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Derivative liabilities:
 
 
 
 
 
 
 
 
Derivative Instruments
 
483,804

 
—

 
—

 
483,804

Total derivative liabilities
 
483,804

 
—

 
—

 
483,804

 
 
 
 
 
 
 
 
 
Total assets and liabilities measured at fair value
 
$
483,804

 
$
—

 
$
—

 
$
483,804


The derivative liabilities above are classified as other long-term liabilities in the December 31, 2019 consolidated balance sheet.
The following table presents the Company’s liabilities that are measured at fair value on a recurring basis at December 31, 2018: 
 
 
 
 
Fair Value Measurements at Reporting Date Using
 
 
Total
 
Quoted Prices in Active Markets for Identical Assets
(Level 1)
 
Significant other
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Derivative liabilities:
 
 
 
 
 
 
 
 
Derivative Instruments
 
498,086

 
—

 
—

 
498,086

Total derivative liabilities
 
498,086

 
—

 
—

 
498,086

 
 
 
 
 
 
 
 
 
Total assets and liabilities measured at fair value
 
$
498,086

 
$
—

 
$
—

 
$
498,086

Fair Value Measurements Using Significant Unobservable Inputs
The following table presents the Company’s liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of each of the years ended December 31, 2019 and 2018: 
 
 
Fair Value Measurements Using
Significant Unobservable Inputs
(Level 3)
 
 
December 31, 2019
 
December 31, 2018
Beginning Balance
 
$
498,086

 
$
445,838

Total (earnings) loss recognized in earnings
 
(14,282
)
 
52,248

Ending Balance
 
$
483,804

 
$
498,086



Earnings and losses resulting from changes in the fair value of the derivative instruments above are recorded as a component of interest and other expense.